Cam Gallagher
CIK: 0001557832
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Opus Genetics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 8, 2026IRD
Opus Genetics, Inc.
Exercise(M)Direct784.3K shares at avg. $1.15$902K - Apr 20, 2026IRD
Opus Genetics, Inc.
Award(A)Direct24.4K shares- - Jan 6, 2026IRD
Opus Genetics, Inc.
Award(A)Direct67K shares- - Dec 31, 2025IRD
Opus Genetics, Inc.
Award(A)Direct33K shares- - Dec 29, 2025IRD
Opus Genetics, Inc.
Purchase(P)Indirect83K shares at avg. $1.97$163K - Dec 29, 2025IRD
Opus Genetics, Inc.
Purchase(P)Direct81K shares at avg. $1.98$160K - Aug 25, 2025IRD
Opus Genetics, Inc.
Award(A)Direct869.6K shares at avg. $1.15$1000K - Apr 30, 2025IRD
Opus Genetics, Inc.
Award(A)Direct79.5K shares- - Mar 24, 2025IRD
Opus Genetics, Inc.
Award(A)Direct784.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | IRD Opus Genetics, Inc. | Exercise(M) | 784,314 | $1.15 | $901,961 | Direct |
| Apr 20, 2026 | IRD Opus Genetics, Inc. | Award(A) | 24,367 | - | $0 | Direct |
| Jan 6, 2026 | IRD Opus Genetics, Inc. | Award(A) | 67,000 | - | $0 | Direct |
| Dec 31, 2025 | IRD Opus Genetics, Inc. | Award(A) | 33,000 | - | - | Direct |
| Dec 29, 2025 | IRD Opus Genetics, Inc. | Purchase(P) | 83,000 | $1.97 | $163,419 | Indirect |
| Dec 29, 2025 | IRD Opus Genetics, Inc. | Purchase(P) | 81,000 | $1.98 | $160,275 | Direct |
| Aug 25, 2025 | IRD Opus Genetics, Inc. | Award(A) | 869,565 | $1.15 | $1,000,000 | Direct |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | Award(A) | 79,504 | - | - | Direct |
| Mar 24, 2025 | IRD Opus Genetics, Inc. | Award(A) | 784,314 | - | - | Direct |
1-9 of 9 transactions
About Gallagher Cam
Gallagher Cam (SEC CIK 0001557832) files insider reports with the SEC as Director of Opus Genetics, Inc. (IRD).
Signal8 holds 7 ownership filings by Gallagher Cam, all Form 4s, filed between Mar 26, 2025 and Sep 8, 2026. Those filings report 9 transactions, from Mar 24, 2025 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gallagher Cam's filings is in DURHAM, NC.
Recent filings by Gallagher Cam
- Sep 8, 2026: Option exercise of IRD shares (Form 4, code M).
- Apr 20, 2026: Grant or award of IRD shares (Form 4, code A).
- Jan 6, 2026: Grant or award of IRD shares (Form 4, code A).
- Dec 31, 2025: Grant or award of IRD shares (Form 4, code A).
- Dec 29, 2025: Open-market purchases of IRD shares (2 lines, Form 4, code P).
Other insiders filing for Opus Genetics, Inc. (IRD)
- SCHACHLE JOSEPH K, Chief Operating Officer
- YERXA BENJAMIN R, President
- Gagnon Robert E., Chief Financial Officer
- Magrath George, Chief Executive Officer
- Foundation Fighting Blindness Retinal Degeneration Fund, Director
- Zaremba Rabourn Amy, Head of Fin. Quality Assurance